Nicole De Nisco, Doctor of Philosophy (PhD)

Dr. Nicole De Nisco is an Associate Professor of Biological Sciences at the University of Texas at Dallas and an Adjunct Assistant Professor in the Department of Urology at the University of Texas Southwestern Medical Center. Her laboratory studies host-pathogen-microbiome interactions that underlie recurrent urinary tract infection (UTI) leveraging shotgun metagenomics, metabolomics, and classic microbiological techniques. The De Nisco lab seeks to understand recurrent UTI susceptibility by interrogating the metabolic relationship between the urinary microbiota and the human host in health and disease. Additional ongoing collaborative projects in the De Nisco lab are focusing on defining interactions between uropathogens and the bladder glycosaminoglycan layer, clinical surveillance of emerging uropathogens, and developing new point-of-care diagnostic tools for UTI. Dr. De Nisco completed her Bachelor of Science (B.S.) in Biology in 2007 at the Massachusetts Institute of Technology in Cambridge, Massachusetts. She earned her Doctor of Philosophy (PhD) in Molecular Biology at the Massachusetts Institute of Technology in 2013 and completed her postdoctoral training at the University of Texas Southwestern Medical Center in 2018.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:10/22/2024Date updated:10/22/2026
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward